Propafenone Hydrochloride
Product manufactured by American Health Packaging
Indications and Purposes
| 1 Indications And Usage Propafenone Hcl Extended Release Capsules Is Indicated To Prolong The Time To Recurrence Of Symptomatic Atrial Fibrillation (Af) In Patients With Episodic (Most Likely Paroxysmal Or Persistent) Af Who Do Not Have Structural Heart Disease. Usage Considerations: The Use Of Propafenone Er Capsules In Patients With Permanent Af Or In Patients Exclusively With Atrial Flutter Or Paroxysmal Supraventricular Tachycardia (Psvt) Has Not Been Evaluated. Do Not Use Propafenone Er Capsules To Control Ventricular Rate During Af. Some Patients With Atrial Flutter Treated With Propafenone Have Developed 1:1 Conduction, Producing An Increase In Ventricular Rate. Concomitant Treatment With Drugs That Increase The Functional Atrioventricular (Av) Nodal Refractory Period Is Recommended. The Effect Of Propafenone On Mortality Has Not Been Determined [See Boxed Warning ] . Propafenone Hcl Extended Release Capsules Is An Antiarrhythmic Indicated To Prolong The Time To Recurrence Of Symptomatic Atrial Fibrillation (Af) In Patients With Episodic (Most Likely Paroxysmal Or Persistent) Af Who Do Not Have Structural Heart Disease. ( 1 ) Usage Considerations: Use In Patients With Permanent Atrial Fibrillation Or With Atrial Flutter Or Psvt Has Not Been Evaluated. Do Not Use To Control Ventricular Rate During Atrial Fibrillation. ( 1 ) In Patients With Atrial Fibrillation And Atrial Flutter, Use Propafenone Er Capsules With Drugs That Increase The Atrioventricular Nodal Refractory Period. ( 1 ) The Effect Of Propafenone On Mortality Has Not Been Determined. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Propafenone Hydrochloride |
|
ZINC1530760 |